BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 10:57:00 AM | Browse: 1168 | Download: 1030
Publication Name World Journal of Stem Cells
Manuscript ID 7395
Country Japan
Received
2013-11-16 11:41
Peer-Review Started
2013-11-16 16:23
To Make the First Decision
2013-12-10 14:35
Return for Revision
2013-12-17 16:31
Revised
2014-01-21 18:47
Second Decision
2014-05-08 17:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-08 17:58
Articles in Press
2014-05-23 13:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-18 11:31
Publish the Manuscript Online
2014-07-19 21:17
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Topic Highlights
Article Title Mesenchymal stem cells for treatment of aortic aneurysms
Manuscript Source Invited Manuscript
All Author List Aika Yamawaki-Ogata, Ryotaro Hashizume, Xian-Ming Fu, Akihiko Usui and Yuji Narita
Funding Agency and Grant Number
Corresponding Author Yuji Narita, MD, PhD, Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-Ku, Nagoya 466-8550, Japan. ynarita@med.nagoya-u.ac.jp
Key Words Aortic aneurysm; Mesenchymal stem cells; Cell therapy; Elastin; Chronic inflammation; Extracellular matrices; Macrophages; Matrix metalloproteinases
Core Tip Aortic aneurysm (AA) is caused by an imbalance between synthesis and degradation of extracellular matrices (ECMs) such as collagen and elastin in the aortic wall. The chronic inflammation enhances the degradation of ECMs directly and indirectly. We hypothesized that administration of mesenchymal stem cells (MSCs) might be able to treat AA given the anti-inflammatory and immune-suppressive potential of MSC. In this article, we review papers that attempt to treat AA using MSCs with our recent results, as well as review the molecular pathogenesis of AA and characteristics of MSC.
Publish Date 2014-07-19 21:17
Citation Yamawaki-Ogata A, Hashizume R, Fu XM, Usui A, Narita Y. Mesenchymal stem cells for treatment of aortic aneurysms. World J Stem Cells 2014; 6(3): 278-287
URL http://www.wjgnet.com/1948-0210/full/v6/i3/278.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i3.278
Full Article (PDF) WJSC-6-278.pdf
Full Article (Word) WJSC-6-278.doc
Manuscript File 7395-Review.docx
Answering Reviewers 7935-Answering reviewers.pdf
Copyright License Agreement 7935-Copyright assignment.pdf
Peer-review Report 7395-Peer review.pdf
Scientific Editor Work List 7935-Scientific editor work list.pdf